Related Experiment Video
Updated: Jan 10, 2026

09:00
High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease
Published on: October 31, 2012
16.2K
Automated endpoint titer ELISAs for high-throughput immunogenicity evaluations using a BioMek i7 liquid handler
Barbara Theriot1, Andrew N Macintyre2
1Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA.
SLAS Technology
|November 20, 2025
Summary
No abstract available in PubMed .

